Latest Ischemia Stories

'Cyborg' tissues could merge bioengineering with electronics for drug development, implantable therapeutics A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities...

Every 40 seconds, someone in the United States has a stroke, usually caused when a clot blocks an artery that supplies blood to the brain. Now the results of two multicenter studies published online in The Lancet on August 26 are giving physicians new innovative tools proven to better remove these clots that block blood flow. The TREVO 2 clinical trial, (Thrombectomy Revascularization of Large Vessel Occlusions in Acute Ischemic Stroke) showed that the Trevo Retriever, a clot-removal...

Stroke is the fourth leading cause of death and a common cause of long-term disability in the United States, but doctors have very few proven treatment methods. Now a new device that mechanically removes stroke-causing clots from the brain is being hailed as a game-changer. In a recent clinical trial, the SOLITAIRE Flow Restoration Device dramatically outperformed the standard mechanical treatment. Findings from the trial, called SOLITAIRE With the Intention for Thrombectomy (SWIFT), are...

"Cyborg" tissues could merge bioengineering with electronics for drug development, implantable therapeutics BOSTON, Aug. 26, 2012 /PRNewswire-USNewswire/ -- A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks--which mark the first time that electronics and tissue have been truly merged in 3D--allow direct tissue sensing and potentially stimulation, a potential boon for...

In the news release, Rockland Technimed Ltd. Presents Oxy-17® Metabolic Magnetic Resonance Imaging Technology at 2012 Brain Energy Metabolism and Blood Flow Gordon Research Conference, issued Aug. 15, 2012 by Rockland Technimed Ltd. over PR Newswire, we are advised by the company that the phone number provided for the media contact was incorrect. The correct media contact phone number is +1-201-512-8721, or +1-845-426-3406. The complete, corrected release follows: Rockland Technimed Ltd....

WATERVILLE, Maine, Aug. 15, 2012 /PRNewswire/ -- Rockland Technimed Ltd., a pioneer in developing metabolic magnetic resonance imaging (MRI) media, today presented the latest research on the potential clinical applications of brain MRI performed with its patented imaging medium, Oxy-17(®). The presentation highlighted the use of Oxy-17(® )MRI to measure two key indicators of cerebral tissue function: cerebral metabolic rate of oxygen (CMRO(2)) and oxygen extraction fraction (OEF)....

CLEVELAND, Aug. 7, 2012 /PRNewswire/ -- A new national study looking at the safety and effectiveness of new medication developed from adult stem cells for the treatment of ischemic stroke has opened at University Hospitals (UH) Case Medical Center. The Phase 2 study will use a cell therapy product called MultiStem(®) developed by the Cleveland-based biotechnology company Athersys. Ischemic stroke is caused by blockage in an artery in or to the brain, that impedes blood flow, and...

SAN DIEGO, July 26, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced the publication of preclinical findings demonstrating that cardiac ischemia plays an important role in adenovector gene delivery (transfection) in mammalian hearts. The new findings were published in the peer-reviewed journal Human Gene Therapy Methods in an article entitled "Ischemia-Reperfusion Increases Transfection Efficiency of Intracoronary Adenovirus type 5 in Pig Heart in Situ," which...

Osteochondritis Dissecansis now being treated successfully at The Center for Regenerative medicine in Miami, according to Dr. A. J. Farshchian MD. Miami, Florida (PRWEB) July 14, 2012 Osteochondritis Dissecansis now being treated successfully at The Center for Regenerative medicine in Miami, according to Dr. A. J. Farshchian MD. This is typically seen in adolescent males, Osteochondritis Dissecans (OCD) is an entity seen at the ossification centers of the bone (these areas are responsible...

Psychological distress was associated with a higher risk of death from stroke, according to a study published in CMAJ (Canadian Medical Association Journal). Psychological distress includes factors such as anxiety, depression, sleeping problems and loss of confidence, and is common in approximately 15%-20% of the general population. Although there is evidence linking psychological distress to coronary artery disease, there is a dearth of data linking psychological distress with the risk...